Poxel reports topline data from TIMES 3 open-label extension of imeglimin in type 2 diabetes Nov. 26, 2019
ACADIA reports phase II topline results on pimavanserin for negative symptoms of schizophrenia Nov. 26, 2019
Clinical activity seen with sitravatinib and nivolumab in refractory urothelial carcinoma Nov. 26, 2019
RSS